JP2006511585A5 - - Google Patents

Download PDF

Info

Publication number
JP2006511585A5
JP2006511585A5 JP2004563981A JP2004563981A JP2006511585A5 JP 2006511585 A5 JP2006511585 A5 JP 2006511585A5 JP 2004563981 A JP2004563981 A JP 2004563981A JP 2004563981 A JP2004563981 A JP 2004563981A JP 2006511585 A5 JP2006511585 A5 JP 2006511585A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
solution
ion
weight
ions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004563981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006511585A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/041038 external-priority patent/WO2004057965A1/en
Publication of JP2006511585A publication Critical patent/JP2006511585A/ja
Publication of JP2006511585A5 publication Critical patent/JP2006511585A5/ja
Pending legal-status Critical Current

Links

JP2004563981A 2002-12-23 2003-12-23 慢性創傷管理における活性酸素種の減少 Pending JP2006511585A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43619702P 2002-12-23 2002-12-23
PCT/US2003/041038 WO2004057965A1 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Publications (2)

Publication Number Publication Date
JP2006511585A JP2006511585A (ja) 2006-04-06
JP2006511585A5 true JP2006511585A5 (cg-RX-API-DMAC7.html) 2007-02-15

Family

ID=32682357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004563981A Pending JP2006511585A (ja) 2002-12-23 2003-12-23 慢性創傷管理における活性酸素種の減少

Country Status (6)

Country Link
EP (1) EP1575359A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006511585A (cg-RX-API-DMAC7.html)
CN (1) CN1744819A (cg-RX-API-DMAC7.html)
AU (1) AU2003303335A1 (cg-RX-API-DMAC7.html)
CA (1) CA2511440A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004057965A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009251711B2 (en) * 2008-04-01 2014-07-17 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
WO2011022757A1 (en) * 2009-08-24 2011-03-03 Queensland University Of Technology Purine-targeted diagnosis and therapy of wounds
WO2013016255A1 (en) * 2011-07-28 2013-01-31 3M Innovative Properties Company Wound-healing compositions and method of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777C2 (de) * 1984-05-07 1986-11-20 Gödecke AG, 1000 Berlin Pharmazeutische topische Zubereitungen
DK0668769T3 (da) * 1992-11-06 2000-10-02 Greystone Medical Group Inc Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
NZ533252A (en) * 2001-11-29 2006-03-31 Greystone Medical Group Inc Treatment of wounds and compositions employed

Similar Documents

Publication Publication Date Title
WO2010144503A3 (en) Antimicrobial textiles comprising peroxide
JP2009519312A5 (cg-RX-API-DMAC7.html)
TW202619727A (zh) 使用jak抑制劑治療化膿性汗腺炎
WO2006074359A3 (en) Non-irritating compositions containing zinc salts
WO2006110187A3 (en) Methods and compositions for the treatment of anxiety disorders
JP2008534516A5 (cg-RX-API-DMAC7.html)
CL2007002705A1 (es) Composicion farmaceutica oftalmica autopreservada que comprende 0,04 a 0,9 mm de iones zinc donde la concentracion de aniones tamponantes es menor que 15 mm.
TW200637839A (en) 1-thio-d-glucitol derivatives
TW200640445A (en) N-halogenated amino acids, N, N-dihalogenated amino acids and derivatives; compositions and methods of using them
WO2009053934A3 (en) Use of metal astringents for the treatment and prevention of hairy heel warts
UA91332C2 (uk) Кристалічна малеатна сіль хіназоліну (варіанти), корисна як антиангіогенний агент
NZ603490A (en) Fungicidal composition and method for controlling plant diseases
NZ533252A (en) Treatment of wounds and compositions employed
ATE553760T1 (de) Verwendung von alverin zur behandlung von hauterkrankungen
WO2008046407A3 (de) Verwendung von deuteriumdioxid zur behandlung von hyperproliferativen erkrankungen der haut
MX2014008455A (es) Uso de una solucion que contiene iones de sulfato para reducir el obscurecimiento o el deslustre de una lamina de acero durante su almacenamiento y lamina de acero tratada por una tal solucion.
MY144306A (en) Aquoues solution of olanexidine, method of preparing the aqueous solution, and disinfectant
JP2007523137A5 (cg-RX-API-DMAC7.html)
WO2006053788A3 (en) Alterations in seborrheic keratoses and their applications
AU2017336807B2 (en) Oxidative reductive potential water solution, processes for producing same and methods of using the same
TW200833708A (en) Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
WO2007047893A3 (en) Use of dasatinib for the treatment of bone metastasis
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных
JP2014094895A (ja) うどん粉病の防除薬及び防除方法
MD2945G2 (ro) Procedeu de tratare a mărului